In a report released yesterday, Matthew Gillmor from Robert W. Baird reiterated a Buy rating on Tenet Healthcare (THC), with a price target of $35. The company’s shares opened today at $25.08.
According to TipRanks.com, Gillmor is a 5-star analyst with an average return of 16.2% and a 61.1% success rate. Gillmor covers the Services sector, focusing on stocks such as Acadia Healthcare, LHC Group, and Amedisys.
Currently, the analyst consensus on Tenet Healthcare is a Moderate Buy with an average price target of $33, representing a 31.6% upside. In a report released today, Citigroup also maintained a Buy rating on the stock with a $35 price target.
.
See today’s analyst top recommended stocks >>
Based on Tenet Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $4.49 billion and GAAP net loss of $9 million. In comparison, last year the company earned revenue of $4.59 billion and had a GAAP net loss of $367 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.
